-Both USFDA & WHO recommend the use of Oseltamivir for the treatment and prevention of Swine flu.

-Treatment should begin at least within 2 days of onset of symptoms of influenza.

-Prophylaxis therapy should start within 2 days of exposure.

-Oseltamivir inhibits the entry of the virus into uninfected cells and the release of recently formed virus particles from infected cells and the further spread of infectious virus in the body.

-If you need to prepare oral suspension for pediatric use, you can use Oseltamivir 75mg capsules to compound a suspension (15mg/ml) using cherry juice.

-Pregnant women should get vaccinated against seasonal and H1N1 flu vaccine when it becomes available.

-There are insufficient human data upon which to base an evaluation of risk of Oseltamivir to the pregnant woman or developing fetus.

-Oseltamivir should be used during pregnancy ONLY IF the potential benefit justifies the potential risk to the fetus.

-Treatment should be under professional medical supervision.